Eren Berber, MD

Appointed
2005

Education & Fellowships

Graduate School - Weatherhead School of Management Case Western University Masters in Business Administration
Masters in Healthcare Business Administration
Cleveland, OH
2020

Residency - Cleveland Clinic
General Surgery
Cleveland, OH
2005

Fellowship - University of California San Francisco Medical Center
Laparoscopic Surgery
San Francisco, CA
1999

Residency - Istanbul University, Istanbul Medical School
General Surgery
Capa, Istanbul, OH Turkey
1998

Medical Education - Istanbul University, Istanbul Medical School
Capa, Istanbul,
1994

Additional Training

• Masters in Business Administration. Case Western Weatherhead School of Management April 2020

Professional Highlights

• Director of Robotic Endocrine Surgery
• Director, Neuroendocrine / Adrenal Tumor Center, 
• Director, Surgical Liver Tumor Ablation Program 
• Co-director of Multidisciplinary Liver Tumor Clinic
  
  

Certifications

• Surgery - General Surgery

Specialty Interests

adrenal disease, Adrenal disorders, Advanced Laparoscopic Surgery, Calcium Disorders, endocrine hypertension, endocrine surgery - thyroid and parathyroid diseases and surgery, endocrine surgery (thyroid and parathyroid), general and laparoscopic surgery, General Surgery, laparoscopic radiofrequency ablation of liver tumors, Laparoscopic Adrenalectomy, laparoscopic radiofrequency ablation of liver tumors, Laparoscopic Solid Organ Surgery, Laparoscopic Surgery, Laparoscopic Thermal Ablation Of Liver Tumors, pancreatic endocrine tumors., Minimally Invasive Surgery, multiple endocrine neoplasia syndromes, parathyroid and calcium disorders, thyroid, Thyroid Cancer, thyroid cancers, Thyroid cancers and Flushing Syndromes, Thyroid Disease, thyroid disorders, thyroid nodules, robotic thyroidectomy, robotic surgery, robotic adrenalectomy. laparoscopic liver resection, image-guided surgery

Innovations & Patents

• Started the Laparoscopic Liver Resection Program with Dr. John Fung, 2006
• Started the robotic endocrine surgery program in 2008
• Did one of the first robotic thyroidectomies and parathyroidectomies in the US
• Did the first robotic posterior adrenalectomy in the world
• Did the first robotic central neck dissection for thyroid cancer in the US
• Did the first robotic liver resection at the Cleveland Clinic
• Did the first fully laparoscopic hemihepatectomy at the Cleveland Clinic
• Used a novel high-power ablation generator to treat large liver tumors for the first time in the world in October 2020.

Memberships

• Society of American Gastrointestinal and Endoscopic Surgeons- Member of tFundomentals of Surgical Energy Committees
• American Hepato-Pancreato-Biliary Association
• American College of Surgeons
• American Hepato-Pancreato-Biliary Association- Member of the Ultrasound Committee
• Central Surgical Society
• American Association of Endocrine Surgeons-Member of Education Committee
• American Thyroid Association
• Clinical Robotics Surgical Association-Treasurer, Committee Chair, Education. 

See publications for Eren Berber, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/29/2024, Dr. Berber has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Berber receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Fluoptics

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.